| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9238160 | Digestive and Liver Disease | 2005 | 6 Pages |
Abstract
H. pylori primary and secondary resistances to clarithromycin and tinidazole are high in our geographic area, while resistance to rifabutin is rare. Rifabutin-based triple therapy, can be successfully used in primary and secondary resistance to clarithromycin and tinidazole according to the in vitro susceptibility test.
Keywords
GGTH. pyloriUBTPPIALTWBCRBCCLA13C-urea breath testASTAspartate aminotransferaseAlanine aminotransferaseALPAlkaline phosphataseAmoxicillinITTtinRapid urease testTinidazoleper protocolRifabutinAMOconfidence intervalintention-to-treatAntibiotic resistanceProton pump inhibitorsClarithromycinGamma glutamyl transpeptidasewhite blood cellred blood cell
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
S. Toracchio, S. Capodicasa, D.B. Soraja, L. Cellini, L. Marzio,